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Identification of emerging bacterial pathogens generally results from a chain of events involving micros-
copy, serology, molecular tools, and culture. Because of the spectacular molecular techniques developed
in the last decades, some authors think that these techniques will shortly supplant culture. The key steps
that led to the discovery of emerging bacteria have been reviewed to determine the real contribution of
each technique. Historically, microscopy has played a major role. Serology provided indirect evidence for
causality. Isolation and culture were crucial, as all emerging bacteria have been grown on artificial media
or cell lines or at least propagated in animals. With the use of broad-range polymerase chain reaction,
some bacteria have been identified or detected in new clinical syndromes. Culture has irreplaceable
advantages for studying emerging bacterial diseases, as it allows antigenic studies, antibiotic susceptibility
testing, experimental models, and genetic studies to be carried out, and remains the ultimate goal of
pathogen identification.
n the last 20 years, advances in knowledge have resulted in
a broad expansion of the spectrum of microorganisms
regarded as human pathogens. Most advances have evolved in
a series of small steps based on several techniques that have
been used successively by different investigators who faced
clinically suspect diseases. These include the traditional tech-
niques of microscopy, serology, and culture, as well as more
recent molecular tools (Figure 1). In addition to aiding in dis-
covering new pathogens, these techniques also contributed to
studies of the epidemiology, pathophysiology, and treatment
response of the newly recognized diseases, providing further
evidence for causal relationships between disease and organ-
ism (1). As a diagnostic and research laboratory specializing in
fastidious, intracellular bacteria, we have been particularly
interested in assessing the specific role played by culture in
identifying emerging pathogens. Historical examples, such as
Lyme or Legionnaires’ diseases, and recent successes, such as
culture of the Whipple bacillus, support the effectiveness of
this technique (2). Moreover, culture provided the basis of
other supplemental tools to elucidate the causes of microbial
disease and to study the clinical and biological features of
emerging bacterial diseases. These tools are not only antigenic
and serologic assays but also in vitro and in vivo disease mod-
els for pathophysiologic studies and antimicrobial susceptibil-
ity testing, plus extensive genetic sequencing. The isolation of
emerging pathogens serves, therefore, not only as a means for
diagnosis but also as a route to enhance understanding of the
diversity and epidemiology of emerging bacteria and the infec-
tions they cause.
Despite these unique advantages, however, culture has
been challenged by the recent development of genotype-based
methods such as broad-range polymerase chain reaction (PCR)
(3). Because culture as a tool is still threatened by the possible
existence of uncultivatable organisms, several authors have
emphasized the critical role that molecular, culture-indepen-
dent techniques could play in further investigations of emerg-
ing infectious diseases, affirming that a reassessment of
Koch’s postulates for disease causation was required (4). What
actually are the respective roles of these two techniques?
Should we consider that broad-range PCR has made culture Unité des Rickettsies, Faculté de Médecine de Marseille, Marseille, France
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Figure 1. Diagram describing the respective places of culture-, poly-
merase chain reaction-, serology- and histology-based approaches for
the diagnosis of acute bacterial infections, according to the natural
course of the disease. Isolation and culture are possible as long as live
bacteria are present in tissues, i.e., from the colonization to the treat-
ment or to the end of the clinical manifestations (or shortly earlier). Bac-
terial DNA can be detected during the same period and also as far as
dead microorganisms remain in tissues. Specific antibodies appear
during the clinical course of the disease and persist generally for
months or years. Pathologic changes can be observed soon after the
contamination and, in an acute infection, will decline rapidly after elimi-
nation of the bacteria.Emerging Infectious Diseases  •  Vol. 8, No. 2, February 2002 123
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and traditional techniques obsolete, or is it only a step among
others in the sequence of events leading to isolation of a new
microorganism? To answer these questions, we examined the
key steps that led to identification of most bacterial diseases
that have been discovered during the last 20 years. Table 1 pre-
sents the main biological evidence that allowed emerging bac-
teria to be recognized and disease causation to be
demonstrated. We examined the contribution of traditional and
molecular techniques to understand their respective roles, and
we emphasize the specific advantages of culture.
Traditional Techniques Other Than Culture: 
Microscopy and Serology
Optic Microscopy
Direct Detection in Smears 
Historically, morphologic methods have played an impor-
tant role in detecting new microorganisms, and they are still
crucial for diagnosing infections caused by agents not rou-
tinely cultured, such as Mycobacterium leprae (40). Because
microscopic examination of stained smears from biologic flu-
ids or tissue imprints is usually rapid and easy, it has often
been performed in patients who have an unexplained disease,
although its interpretation is subjective and its sensitivity and
specificity are generally low. The first evidence for the respon-
sibility of Ehrlichia species in humans with an acute febrile ill-
ness was provided by examining blood smears stained with a
Romanowsky stain, in which these as-yet-uncultivated organ-
isms could be observed forming intracytoplasmic morulae
within leukocytes (6,7). Borrelia burgdorferi were first
observed in Giemsa-stained smears from midgut diverticula of
ticks (19). Examination of smears can also be helpful when
multiple organisms are cultured from a nonsterile site, as
microbial culture alone, as well as molecular detection, cannot
distinguish between colonization or asymptomatic shedding
and tissue invasion: in such a situation, the morphology of the
predominant organism visualized in the tissue sections can
suggest the true causative agent (40).
Detection in Tissue Sections 
Although individual bacteria generally are not detected in
hematoxylin and eosin (H&E)-stained tissue sections, excep-
tions do exist. Clumps of finely particulate basophil material
were seen in H&E-stained sections of bacillary angiomatosis
and subsequently identified as Bartonella (41). In H&E-
stained sections of gastric biopsy specimens that show acute
gastritis, curved bacteria consistent with Helicobacter pylori
may be seen in the layer of mucus on the crypt epithelium
(25). Moreover, as histopathologic damage and causal micro-
organisms usually have a long-established association, micro-
scopic examination of H&E-stained tissue sections during the
course of an unexplained disease may lead to hypotheses about
the nature of the etiologic agent (40).
Gram stain has also proven useful to routinely diagnose H.
pylori and H. heilmanii in the gastric mucosa of patients with
gastritis, as well as that of B. henselae in cardiac valves
(10,24,25). Silver impregnation is among the most useful
methods for detecting bacteria, especially for that stained
weakly with a tissue Gram stain. Thus, bacillary angiomatosis
lesions were found to contain clusters of bacilli on Warthin-
Starry staining 2 years before the etiologic role of B. henselae
was elucidated. With the same stain, this bacterium was also
detected in cardiac valves of patients with endocarditis (Figure
2)(41). The first observation of Whipple agent was reported in
1907 by George Whipple in silver-stained sections of a lymph
node, although the author did not link this observation with the
cause of the disease (2).
Special stains have also played a role in establishing the
etiologic role of new bacteria. Gimenez’ and Pinkerton’s stains
allowed the detection of rickettsial organisms in tissue sections
from patients with acute febrile disease (40). New mycobacte-
ria were initially detected by using Ziehl-Nielsen, Kinyoun, or
auramine O stains. For example, in an HIV-infected boy,
examination of a retroperitoneal lymph node showed granu-
loma with large numbers of intracellular acid-fast bacilli that
were later characterized as a new Mycobacterium species, M.
genavense (34). Morphologic techniques, indeed, do not allow
specific identification of the detected organisms. Despite this
limitation, the approach consisting of detecting infectious
lesions and agents by using cytologic and histologic examina-
tion appeared to be sometimes more valuable than the cultural
or molecular techniques (40).
Electron Microscopy
Among morphologic techniques, transmission and scan-
ning electron microscopy (EM) has substantial advantages
resulting from its high flexibility and sensitivity (42). Negative
staining is a rapid EM method that can be useful in patients
with persisting or unexplained disease. Further, its specificity
and sensitivity can be enhanced by using immunocapture
assay. Thus, in patients with chronic gastritis, EM provided the
first detection of H. pylori in the gastric mucosa (25). EM can
resolve details many hundreds of time smaller than can be seen
through light microscopes, and resolution of major taxonomic
features can help to characterize new microorganisms (42).
Thus, the agent of Whipple disease was recognized as a bacil-
lus through ultrastructural examination of the bacilli (42).
Nevertheless, limitations of EM include its availability, cost,
and need for experienced staff. EM requires knowledge of his-
tology and ultrastructure of the tissue being examined and
organisms likely to be encountered and is very time-consum-
ing, since every specimen must be examined individually (42).
Serology and Antigenic Detection
Serology
By showing rising antibody titers or seroconversion, serol-
ogy can provide indirect evidence for causal relationshipsPERSPECTIVES
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Table 1. Key steps that led to identification and demonstration of disease causation for emerging bacteriaa
Group Species Clinical picture
Histologic 
detection Serology
Molecular
 detection
 (gene) Culture system
Year of 
culture Ref.
Alpha1 Proteobacteria
Ehrlichia chaffeensis Fever, cytopenia Smear Antibodies to Ehr-
lichia canis
16S rRNA Cell line (DH82) 1991 5
E. ewingii Fever, cytopenia Smear Western blot 16S rRNA Cell line 1971 6
Human granulocytic 
Ehrlichia
Fever, cytopenia Smear Antibodies to E. 
phagocytophila, E. 
equis
16S rRNA Cell line (HeLa) 1996 7
Rickettsia felis Fever gltA Cell line (XTC-2) 2000 8
R. japonica Spotted fever Antibodies to Spot-
ted fever group 
rickettsiae
Cell line (Vero) 1989 9
R. mongolotimonae Febrile rash Antibodies to Spot-
ted fever group 
rickettsiae
rOmpA Embryonated egg, 
guinea pig
1991 10
R. slovaca Fever, eschar, lym-
phadenitis
Specific antibodies rOmpA Cell line 1968 11
Alpha2 Proteobacteria
Afipia broomae Wrist abscess Axenic (specific) 1981 12
A. clevelandensis Osteitis Axenic (specific) 1988 12
Bartonella elizabe-
thae
Endocarditis Axenic (nonspecific) 1993 13
B. grahamii Neuro-retinitis Antibodies to
B. henselae
16S rRNA Axenic (nonspecific) 1995 14
B. henselae Fever, cat scratch dis-
ease, bacillary angi-
omatosis
Tissue section Specific antibodies 16S rRNA Axenic (nonspecific) 1990 15,16
Beta Proteobacteria
Bordetella trematum Chronic otitis Axenic (nonspecific) 1996 17
Neisseria weaveri Infected wound Axenic (nonspecific) 1993 18
Spirochetae
Borrelia burgdorferi 
sensu stricto, B. 
afzelii, B. garinii
Erythema chronicum 
migrans, acroderma-
titis chronica atrophi-
cans, Lyme arthritis, 
neuro-borreliosis 
Specific antibodies Axenic (specific) 1981 19
B. duttonii Relapsing fever Smear Specific antibodies Axenic (specific), ani-
mal model
1999 20
B. recurrentis Relapsing fever Smear Axenic (specific) 1994 21
Delta-Xi Proteobacteria
Campylobacter coli, 
C. jejuni
Febrile diarrhea Specific antibodies Axenic (nonspecific) 1977 22
Helicobacter cinaedi, 
H. fennelliae
Rectitis Axenic (nonspecific) 1984 23
H. heilmanii Chronic gastritis Tissue section Mouse 1989 24
H. pylori Gastritis, gas-
troduodenal ulcer
Tissue section Specific antibodies Axenic (nonspecific) 1982 25
Gamma Proteobacteria
Escherichia coli 
O48:H21, O103:H2, 
O157:H7
Bloody diarrhea, 
HUS
slt Axenic (nonspecific) 1982-1996 26
Haemophilus 
influenzae biogroup 
aegyptius
Brazilian purpuric 
fever
Axenic (nonspecific) 1986 27Emerging Infectious Diseases  •  Vol. 8, No. 2, February 2002 125
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Table 1 cont’d. Key steps that led to identification and demonstration of disease causation for emerging bacteriaa
Group Species Clinical picture
Histologic 
detection Serology
Molecular
 detection
 (gene) Culture system
Year of 
culture Ref.
Gamma Proteobacteriae
Legionella anisa Pneumonia, Pontiac 
fever
Specific antibodies Axenic (specific) 1989 28
L. bozemanii Pneumonia Smear Specific antibodies Axenic (specific) 1983 29
L. dumoffii Pneumonia Smear Specific antibodies Axenic (specific) 1978 29
L. feeleii Pneumonia, Pontiac 
fever
Specific antibodies Axenic (specific) 1986 30
L. micdadei Pneumonia Specific antibodies Embryonated egg, 
guinea pig
1979 29
L. oakridgensis Pneumonia Smear Specific antibodies Axenic (specific) 1987 29
L. pneumophila Pneumonia Tissue section Specific antibodies Embryonated egg, 
guinea pig
1947 31
Legionella like 
amoebal pathogen
Pneumonia Specific antibodies Amoeba 1991 32
Vibrio alginolyticus Conjunctivitis, 
wound infection
Axenic (nonspecific) 1977 33
V. cholerae O:139 Diarrhea Axenic (nonspecific) 1992 33
V. fluvialis Diarrhea Axenic (nonspecific) 1980 33
V. furnissii Diarrhea Axenic (nonspecific) 1983 33
V. metschnikovii Cholecystitis Axenic (nonspecific) 1981 33
V. mimicus Diarrhea, otitis Axenic (nonspecific) 1981 33
Mycobacteria
Mycobacterium 
asiaticum
Pneumopathy Axenic (specific) 1983 34
M. celatum Pneumopathy Axenic (specific) 1992 34
M. genavense Disseminated infec-
tion, lymphadenitis
Tissue section Axenic (specific) 1992 34
M. malmoense Pneumopathy, lym-
phadenitis
Axenic (specific) 1977 34
M. simiae Pneumopathy, 
osteitis, kidney 
infection
Axenic (specific) 1984 34
Mycoplasmas
M. fermentans Pneumopathy, 
nephritis
Tissue section Insertion 
sequence-like
Axenic (specific) 1993 35
M. genitalium Urethritis Smear Adhesion 
protein
Axenic (specific),
Animal model
1981 35
Gram-positive bacteria
Tropheryma whip-
plei
Whipple disease Tissue section Specific antibodies 16S rRNA Cell line
(HEL)
2000 2,36
Corynebacterium 
auris
Acute otitis  Axenic (nonspecific) 1995 37
Staphylococcus 
lugdunensis, S. 
schleiferi
Skin abscess, 
osteoarthritis
Axenic (nonspecific) 1988 38
Streptococcus iniae Meningitis, 
endocarditis, 
cellulitis
Axenic (nonspecific) 1995 39
aHistologic detection can be performed with morphologic techniques, in blood or tissue smears, or in tissue sections. Serologic assays can detect specific antibodies to the suspected 
agent or to a related organism in tissues or in biological fluids. The year of the first isolation and the culture system used are indicated. 
HUS = hemolytic uremic syndrome. HLE=human embryonic lung fibroblasts; ref = reference.PERSPECTIVES
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between a disease and a newly identified bacterium. Con-
versely, in the absence of serologic evidence, the role of a cul-
tured organism should be interpreted cautiously, as shown by
the example of Afipia felis, which was first thought to be the
cause of cat-scratch disease, but was finally identified as a
water contaminant (12,43). Serology is also useful to assess
the involvement in human diseases of microorganisms that had
been initially recovered from the environment, such as novel
Legionella species, or from animal hosts, as for the tick-asso-
ciated bacteria Borellia burgdorferi or Rickettsia slovaca
(11,19,29). Further, serology is a valuable tool for exploring
the disease spectrum of a bacterium. Thus, serologic testing
contributed to the recognition of B. henselae as the main agent
of cat-scratch disease (16), as well as implicating Campylo-
bacter jejuni as a possible cause of Guillain-Barré syndrome (44).
Moreover, the contribution of serologic studies to the iden-
tification of new bacterial pathogens should not be underrated.
Serologic cross-reactions are common between members of
the same bacterial genus, and antibodies specific to a bacterial
species can suggest the role of a closely related, still unidenti-
fied organism. Thus, specific antibodies to Ehrlichia canis, E.
phagocytophila, and E. equis, then known only as veterinary
pathogens, were detected in patients and led to description of
the agents of human ehrlichioses (E. chaffeensis, E. ewingii,
and human granulocytic ehrlichiosis) (5-7). Involvement of
Bartonella grahamii in neuroretinitis was first suggested by
detection of specific antibodies to B. henselae in the patient’s
blood (14). Reliable interpretation of such serologic cross-
reactions, however, would not have been possible without con-
sidering other evidence, such as intraleukocytic morulae for
ehrlichioses.
Antigenic Detection
Production of specific antibodies in experimental animal
studies allowed immunochemical detection techniques to be
developed. Direct immunofluorescence staining can be per-
formed in smears in respiratory fluids of patients with pneu-
monia (29). Immunohistochemistry is useful for demonstrating
disease causation, as it provides evidence for in situ associa-
tion between microorganisms and histologic structures. With
this technique, Tropheryma whipplei was detected in a
patient’s mitral valve and later in intestinal mucosae (Figure 3)
(2). Immunohistochemistry also suggested the role of M. fer-
mentans in pulmonary infections (35). Immunologic tech-
niques are dependent, however, on the availability of specific
antibodies or antigens, which in most cases requires previous
isolation of the agent; therefore, such techniques indirectly
contribute to culture.
Culture: A Traditional Technique of Expanding 
Potential
Culture Media
Axenic Media
Broad-spectrum media allowed several previously unrec-
ognized gram-positive bacteria, such as novel corynebacteria
or Staphylococcus species, as well as novel beta-Proteobacte-
ria, to be isolated, mainly from blood or pus of patients
(18,37,38). The first isolation of B. elizabethae, B. quintana,
and B. henselae was also achieved on blood agar (15). Use of
Campylobacter-selective medium allowed novel Campylo-
bacter and Helicobacter species to be grown from stools and
rectal swabs, respectively (23), and provided further evidence
for the association between C. jejuni infection and Guillain-
Barré syndrome (44). For Campylobacter spp., selective, anti-
biotic-containing media could be satisfactorily replaced by
nonselective blood agar, provided stool specimens had been
filtered with a cellulose acetate membrane (23). Newly recog-
nized serotypes of enterohemorrhagic Escherichia coli were
isolated on MacConkey-sorbitol agar from stools or urine of
patients with hemolytic-uremic syndrome (26). For Vibrio
cholerae O:139 and most novel Vibrio species, the most con-
venient, highly selective medium was thiosulfate-citrate-bile
salts sucrose agar (33).
Figure 2. Demonstration of Bartonella henselae in cardiac valve of a
patient with blood culture-negative endocarditis. The bacilli appear as
black granulations (Warthin Starry, original magnification X250).
Figure 3. Demonstration of Tropheryma whipplei by immunohistochem-
istry in the lamina propria of the villous tips. Bacilli are revealed in
foamy macrophage cytoplasm as red-brown deposits (polyclonal rabbit
anti-T. whipplei antibody at a dilution of 1:500, hemalyn counterstain,
original magnification X250).Emerging Infectious Diseases  •  Vol. 8, No. 2, February 2002 127
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The usefulness of broad-spectrum media should not
obscure the fact that some emerging bacteria would not have
been isolated without specific media. Buffered charcoal-yeast
extract (BCYE) agar facilitated the recovery of most novel
Legionella species, as well as Afipia broomeae and A. cleve-
landensis, from human respiratory sources (12,29) The first
cultivation of Borrelia burgdorferi was achieved in 1981 in a
modified Kelly medium (19). In 1994, 20 years after the first
attempts, the Kelly growth medium itself allowed first cultiva-
tion of B. recurrentis from the blood of an Ethiopian patient
with louse-borne relapsing fever, and B. duttonii, agent of East
African tick-borne relapsing fever, was isolated for the first
time in 1999 in BSK II medium (21). Generally, combining
different types of medium, using both solid and liquid media,
increases the effectiveness of culture, perhaps because of a
preference of the bacterium for one type of medium over
another or simply from the increased sensitivity obtained by
culturing a large volume of specimen. For example, B. elizabe-
thae and B. henselae were detected in BACTEC blood culture
medium before inoculation in blood agar (13,15). Isolation of
most novel Mycobacterium species required both solid- and
liquid-specific media (34).
Living Systems
While more expensive and less easy to use than artificial
media, animal models can provide certain advantages not
available with artificial media. For example, until recently,
inoculation to mice was the only means available to propagate
B. duttonii (21). Today, animals are still necessary for isolating
organisms such as Treponema pallidum or Mycobacterium lep-
rae. Animal inoculation can help to reduce the contaminant
flora. Thus, a combination of passage in guinea pigs and sub-
sequent transfer into embryonated eggs was the key for isolat-
ing  L. pneumophila from lung autopsy specimens (31).
Embryonated eggs themselves have been recognized as a stan-
dard for rickettsial isolation, allowing, for example, the first
isolation of Astrakhan fever rickettsia (45).
Cell culture is easy to use and may be very sensitive. Isola-
tion of T. whipplei was obtained from valve and duodenal
biopsy specimens by using human embryonic lung fibroblasts
(HEL) (2,36). Ehrlichia chaffeensis and R. japonica were
grown from blood samples of patients on canine macrophage
cells (Figure 4) and African green monkey cells, respectively
(9,46). Cultivation of facultative intracellular bacteria also was
facilitated by cell culture. L. pneumophila has been isolated by
using HEL cells while inoculated BCYE and agar plates
remained sterile (47). With a bovine endothelial cell line, B.
quintana was isolated for the first time from cutaneous biopsy
material of a bacillary angiomatosis patient (48). Such
enhanced sensitivity is a major advantage for an infection with
low levels of bacteremia or when limited biopsy material is
available (49). Indirectly, HEL cells also provided the first evi-
dence for the role of a toxic factor in pseudomembranous coli-
tis, which could be neutralized by clostridial antiserum. This
observation led to the discovery of Clostridium difficile as the
responsible agent (50).
The search for appropriate media that could allow the
growth of still uncultivatable or unrecognized bacteria has led
us to try coculture with nonmammalian cells. Cell lines from
toads (XTC-2) have been used in our laboratory to grow Rick-
ettsia felis, a flea-associated Rickettsia pathogenic for humans
(8). Coculture with arthropod cells will probably enhance our
ability to detect intracellular, arthropod-transmitted bacteria.
For example, tick cells (IDE8) have been used to grow the
agent of human granulocytic ehrlichiosis (7). Cocultivation of
samples with free-living amebae has allowed recovery of oth-
erwise uncultivatable microorganisms from patients and the
environment. This technique provided evidence for the role of
several  Legionella or Legionella-like species and of
Parachlamydia acanthamoeba as etiologic agents of commu-
nity-acquired pneumonia (51).
Other Critical Issues in Culture
In addition to the choice of an appropriate medium, the
main critical issues in culturing concern inoculation of the
specimen and incubation of the culture, both summarized in
Table 2. Since successful culture usually results from the
selection of a unique cultivatable clone, the quantity of
injected pathogen should be as high as possible. Samples
should be collected from anatomic sites that are likely to con-
tain a high concentration of bacteria, and injection of a large
volume of tissue sample is preferable. In patients with Bar-
tonella endocarditis, the sensitivity of cell cultures has been
shown to be higher when performed with valvular biopsy sam-
ples than with peripheral blood samples (49). These criteria,
however, are not always feasible, as patients may reject, for
instance, invasive explorations that are required to obtain the
specimens. Arthropod-transmitted bacteria, which are often
rare in infected human tissues, may be sometimes more easily
recovered from samples collected from infected vectors; this
Figure 4. Canine monocytes (DH82) cultivated in vitro and heavily
infected with Ehrlichia chaffeensis, as viewed by light microscopy after
Giemsa staining. Typical ehrlichial inclusions (morulae) are observed
within the cytoplasm of the infected cells (Giemsa, original magnifica-
tion X600).PERSPECTIVES
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was the key leading to the identification of B. burgdorferi (19).
If initially such a result was insufficient in a clinical diagnostic
approach, it has since led to efficient serologic and molecular
tools, which would not have been available without culture.
For intracellular bacteria, the use of a lysis method for eukary-
otic cells before inoculation substantially enhances the ability
to grow the organisms, especially when inoculation is per-
formed in an axenic media, as for Bartonella or Mycobacte-
rium species (15). Since low-speed centrifugation may also
increase infectivity, the centrifugation-shell vial technique for
isolating cytomegalovirus has been adapted to detect intracel-
lular bacteria and used successfully to cultivate Rickettsia spe-
cies from blood and skin biopsies and T. whipplei from the
mitral valve of a patient with endocarditis (2).
Special attention should be accorded to the duration, tem-
perature, and atmosphere of incubation. For some of the most
important newly discovered pathogens, such as H. pylori,
patience has been a key to successful cultivation (25). With T.
whipplei, the first evidence of cytopathic effect and microor-
ganisms did not occur until day 65 after inoculation (2). Isola-
tion of Bartonella henselae from blood or tissue samples from
infected patients required up to 33 days’ incubation (15,49).
Although most pathogenic bacteria have been cultured at 35°C
to 37°C, which is close to the physiologic temperature of the
human body, several pathogens need a lower temperature. In
addition to well-known examples such as M. leprae and Tre-
ponema pallidum, several arthropod-borne pathogens, includ-
ing arboviruses, Yersinia pestis,  B. bacilliformis, or R. felis
may be more easily cultivated at <32°C (8).
A More Recent Technique: 16S rDNA Amplification 
and Sequencing
With the use of universal primers that recognize highly
conservative loci such as the 16S rDNA encoding gene, spe-
cies-specific sequences can be amplified directly from dis-
eased host tissues and compared with a reference-sequence
database to infer phylogenetic relationships (3,4). This broad-
range PCR technique has expanded the ability of laboratories
to partially characterize organisms that had never been cul-
tured. Thus, in the last decade, it has enabled two unexplained
illnesses to be associated with novel etiologic agents: B.
henselae in bacillary angiomatosis and 1 year later T. whipplei
in patients with Whipple disease (52,53). These remarkable
successes of molecular techniques, however, should not
obscure the fact that a bacterial origin was previously estab-
lished for both diseases on the basis of histologic studies and
clinical responses to antimicrobial treatment (2,48). Further,
isolation and culture were achieved at the same time as molec-
ular identification (for B. henselae) or soon after (for T. whip-
plei) (2,15). In both cases, successful isolation resulted from
laboratory practices generally used to enhance the detection of
fastidious pathogens. Although it has been suggested that spe-
cific culture conditions could be inferred from molecular phy-
logenetic data, such a situation has never occurred for any
bacterium (3). These examples suggest, therefore, that molecu-
lar techniques are particularly useful for taxonomic studies and
identification, while traditional methods remain powerful to
detect pathogens.
For viruses, several species, such as the Sin Nombre virus
(SNV) or the Hepatitis C virus (HCV), were detected by
reverse transcriptase PCR before any morphologic, serologic,
or cultural detection. Although SNV was subsequently cul-
tured in vitro, the HCV agent has only been cultured recently
in chimeric mice (54). Because of its high sensitivity, broad-
range PCR also expands the ability to detect organisms present
in very low quantity and those that are difficult to grow, such
as intracellular bacteria. Ehrlichia ewingii, previously known
as a canine parasite, was detected by this technique in circulat-
Table 2. Key issues for isolating main emerging bacteria
Medium Conditions for incubation
Group
Axenic specific 
medium
Living system 
(embryonated 
egg, cell line)
Low temperature
(<37°C) O2 and CO2 conditions Extended incubation
Alpha1 Proteobacteria Ehrlichia sp.
Rickettsia sp.
Chlamydia sp.
ELB agent
(“Rickettsia felis”) 
(28°C)
Ehrlichia sp.
Rickettsia sp.
Alpha2 Proteobacteria Afipia sp. Afipia sp.
Bartonella sp.
Bartonella bacillifor-
mis (28°C)
Bartonella sp.
Spirochetae Borrelia sp. Treponema pallidum
Delta-Xi Proteobacteria  Campylobacter sp. 
(microaerophilic)
Helicobacter sp. 
(microaerophilic)
Helicobacter pylori
Gamma Proteobacteria  Legionella sp. Legionella sp. Yersinia pestis
Mycobacteria Mycobacterium sp. Mycobacterium leprae Mycobacterium malmoense 
(microaerophilic)
Mycobacterium sp.
Mycoplasmas Mycoplasma sp. Mycoplasma 
fermentans
Gram-positive bacteria Tropheryma 
whipplei
Clostridium difficile
(anaerobic)
Tropheryma whippleiEmerging Infectious Diseases  •  Vol. 8, No. 2, February 2002 129
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ing leukocytes of four patients with febrile illness. Note, how-
ever, that morulae had been identified in neutrophils from two
of the four patients, providing strong evidence for an ehrlichial
origin for the disease, and that serologic evidence was reported
before the PCR assays (6). Advantages of molecular tech-
niques seem more obvious for Bartonella grahamii and B. vin-
sonii subsp. berkhoffii, which have been implicated in human
disease solely on the basis of 16S rDNA amplification and
sequencing (14,55). Molecular tools are also particularly use-
ful in diseases associated with dormant or latent organisms,
such as chronic Lyme arthritis, and for which the sensitivity of
culture from body fluids remains very low (4,). The advan-
tages of broad-range PCR, however, are offset by the problem
of microbial DNA contamination. Even after rigorous techni-
cal precautions are taken to minimize contamination of PCR
reaction, false-positive reactions can occur. Another noticeable
limitation of broad-range PCR is the examination of sites that
are not normally sterile, such as feces or sputum; use of fam-
ily-restricted primers, in situ hybridization with specific
nucleic probes, or expression library screening with immune
sera may help to evercome such limitations (3,4). Another
potential problem is interpretation of the microheterogeneity
found in microbial sequences derived directly from host tis-
sues, especially when these sequences become the sole basis
for defining the existence of an organism. For example,
attempts to characterize and classify nanobacteria using 16S
rDNA sequence analysis provided doubtful results, and these
organisms were later considered contamination (56). Addition-
ally, current databases contain an insufficient number of
entries with which to define species and other taxon bound-
aries over a wide range of microorganisms (3).
Advantages of Culture for the Study of Emerging 
Bacterial Diseases
Antibiotic Susceptibility Testing
When culture and isolation are achieved, susceptibility of
emerging bacteria to a large panel of antimicrobial drugs can
be easily tested, providing essential data to guide clinical treat-
ment, particularly when resistant strains are reported and
empiric therapy may be ineffective. This antimicrobial testing
would have been difficult, if not impossible, with molecular
techniques, as genetic determinants of antibiotic resistance
have been identified in only a few situations (57). Thus, isola-
tion of H. pylori has revolutionized the treatment of duodenal
ulcers, which are now definitively healed by appropriate anti-
microbial regimens. As strains resistant to either metronida-
zole or clarithromycin have been increasingly reported, culture
of the agent is very helpful in case of proven treatment failure,
to assess the antibiotic resistance pattern of local strains of H.
pylori (58). Coculture of bacteria with cell lines has brought
new insights about antibiotic susceptibility patterns for obli-
gate and facultative intracellular organisms. For example,
while patients with human ehrlichiosis have been treated for a
long time, with variable results, with chloramphenicol, in vitro
studies showed that E. chaffeensis was resistant to this antibi-
otic (59).
Experimental Animal Models for Pathogenicity 
With viable microorganisms, disease models can often be
established in animals. Rodent models are the most commonly
used. For Legionella oakridgensis, originally isolated from
industrial cooling towers, demonstration of its pathogenicity
for guinea pigs suggested for the first time, before any clinical
involvement, that it might be an unrecognized human patho-
gen (29). For assessing the capability of various Vibrio species
to elaborate an enterotoxin, rabbit and mouse intestinal models
were used (33). Human tissues can also now be maintained in
immunodeficient mice (SCID-hu), which can then serve as
useful models for human host-specific pathogens (56,60).
Although less accessible, primate models supported, for exam-
ple, the implication of Mycoplasma genitalium in genital tract
infections (35). Finally, experimental animal models are useful
for immunization studies, as for H. pylori in mouse and pri-
mate models. Following culture, immunodominant antigens
can be cloned, expressed, and inoculated to animals to identify
candidate vaccines (61).
Genetic Studies
Isolated Genes
For noncultured organisms, molecular techniques have
been proposed to identify isolated bacterial genes directly
from clinical specimens. These techniques, however, are quite
difficult to use and can identify only a few, short genetic frag-
ments (3). On the other hand, by providing pure microbial cell
mass, culture enables genes to be identified in high numbers
through recombinant chromosomal libraries built from the
extracted DNA. Genes identified in this fashion can then be
utilized as more refined diagnostic tools. For example, Rickett-
sia mongolotimonae and R. slovaca were associated with
human disease on the basis of amplification of a species-spe-
cific  rOmpA gene fragment from skin biopsy specimens
(11,12). DNA probes developed after isolation of Chlamydia
pneumoniae enabled this organism to be detected by in situ
hybridization in coronary atherosclerotic plaques (62). Further,
molecular subtyping of cultured strains has offered new per-
spectives for epidemiologic studies. Thus, comparison of
nucleotide sequences of 16S rDNA, OspA, and Fla genes for
different strains of B. burgdorferi provided phylogenetic data
that consistently supported the division of B. burgdorferi sensu
lato into three geographically distinct genotypes, which were
subsequently shown to have different pathogenic potentials
(63). Correlation between genotypes and biologic characters is
a key to understanding the pathophysiology of bacterial dis-
eases.
Complete Genome Sequence
Because of the importance of organisms such as H. pylori,
M. genitalium, and C. pneumoniae as emerging human patho-
gens and the value of complete genome sequence information
for drug discovery and vaccine development, the completePERSPECTIVES
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nucleotide sequences of these three organisms has been deter-
mined by the whole-genome random sequencing method as
described initially for Haemophilus influenzae. Sequence anal-
yses allowed identification of several predicted coding regions
that included genes required for DNA replication, transcription
and translation, DNA repair, cellular transport, and energy
metabolism (64). With the availability of complete genome
sequences, further assessment of microbial genetic diversity is
possible; based on the large number of sequence-related genes
encoding outer membrane proteins, H. pylori was predicted to
use recombination as a mechanism for antigenic variation and
adaptative evolution (65). As the genome sequences of new
bacterial species or strains are determined, comparative
genomics will be an increasingly useful method to provide
insights into physiologic differences among microorganisms
(64).
Conclusion 
A comprehensive study of the histories of emerging bacte-
rial diseases provided new insights into the respective roles
played by the different identification techniques. Because of
the spectacular development of molecular methods, traditional
techniques have been prematurely considered obsolescent. We
hope to have shown, however, that such a statement does not
reflect the real contribution of these techniques. The
undoubted value of novel molecular methods, especially for
rapid bacterial detection and phylogenetic studies, should not
hide the crucial role that traditional techniques have histori-
cally played. Moreover, these traditional techniques have
never stopped evolving towards increased sensitivity and spec-
ificity. Today, these techniques appear complementary. If
broad-range PCR was helpful in determining the taxonomic
position of new, still uncultured organisms, most of the novel
infectious diseases were finally described after culture and iso-
lation of the responsible agents. In the current, fast-changing
world of emerging infections, fulfillment of Koch’s postulates,
which requires culture, remains a very necessary model of rig-
orous proof and scientific thinking (1). Culture is still an irre-
placeable key for studying emerging bacterial diseases, even if
routine diagnosis can be efficiently achieved by using other
(although generally culture-derived) tools, including genetic
amplification. The history of infectious diseases shows that no
human bacterial pathogen is uncultivable so far: the real issue
seems to be whether we are able to determine the environmen-
tal conditions required by prokaryotic agents for growth (2).
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